This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Nocturia Associated With Nocturnal Polyuria
and you are
between 18 and 65
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Documentation of the efficacy and safety of desmopressin (Nocturin®) 0.1 mg tablet. Observation of patients with benign prostate syndrome, in whom nocturia associated with nocturnal polyuria is treated with desmopressin (Nocturin®) 0.1 mg tablet focusing on number of nocturnal voids, ratio of night/24-h urine volume (%), duration of first undisturbed sleep period and quality of life.

Provided treatments

  • Drug: desmopressin
Tris trial is registered with FDA with number: NCT00902265. The sponsor of the trial is Ferring Pharmaceuticals and it is looking for 138 volunteers for the current phase.
Official trial title:
Efficacy and Safety of Nocturin 0.1 mg Tablets in Treatment of Nocturia in Patients With Nocturnal Polyuria, Lower Urinary Tract Symptoms (LUTS) and Benign Prostate Syndrome (BPS).